Quick Answer
AtriCure, Inc. reported Stockholders Equity of $491.94 million for fiscal year 2025.
AtriCure, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $491.94M | +6.7% |
| 2024 | $460.97M | -1.1% |
| 2023 | $466.17M | +2.1% |
| 2022 | $456.75M | -5.6% |
| 2021 | $483.76M | +17.3% |
| 2020 | $412.39M | +66.7% |
| 2019 | $247.34M | -0.8% |
| 2018 | $249.38M | +54.7% |
| 2017 | $161.17M | -4.3% |
| 2016 | $168.44M | -9.8% |
| 2015 | $186.69M | +40.9% |
| 2014 | $132.54M | +82.5% |
| 2013 | $72.60M | +480.8% |
| 2012 | $12.50M | -19.9% |
| 2011 | $15.62M | -6.7% |
| 2010 | $16.74M | -2.1% |
| 2009 | $17.09M | -41.3% |
| 2008 | $29.12M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $476.51M | +2.5% | +2.6% |
| June 30, 2025 | $464.49M | +0.5% | +2.2% |
| March 31, 2025 | $454.62M | -0.4% | -1.4% |
| December 31, 2024 | $460.97M | -1.1% | -0.9% |
| September 30, 2024 | $465.02M | +0.5% | +0.6% |
| June 30, 2024 | $462.08M | -0.1% | +1.3% |
| March 31, 2024 | $456.31M | +0.3% | -2.1% |
| December 31, 2023 | $466.17M | +2.1% | +0.7% |
- AtriCure, Inc. showed an increase of +6.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, AtriCure, Inc.’s stockholders equity has grown by 1589.4% (from $29.12 million to $491.94 million).
- The most recent figure is from AtriCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: